Full-length ArticleMiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R

Add time:08/16/2019    Source:sciencedirect.com

T helper cells 17 (Th17) are recognized as key participants in the pathogenesis of chronic autoimmune diseases such as multiple sclerosis (MS). Regulation of Th17 differentiation is a valuable strategy for diagnosis and treatment of these complicated immune disorders. Here, by genome-wide expression profiling of microRNAs (miRs), we screened miR-30a, whose level was greatly decreased during Th17 differentiation and the process of demyelination disease, both in MS patients and experimental autoimmune encephalomyelitis (EAE) mice. Enforced constitutive expression of miR-30a in naïve T cells inhibited their differentiation into Th17, and in vivo overexpression of miR-30a resulted in fewer Th17 and alleviative EAE. Moreover, target prediction analysis and dual luciferase report assay revealed that interleukin-21 receptor (IL-21R) was a direct target of miR-30a, a finding consistent with the results that miR-30a downregulated the expression of IL-21R, while overexpression of IL-21R alleviated the inhibitory effect of miR-30a on Th17 differentiation. Taken together, our findings imply that miR-30a inhibits Th17 differentiation and the pathogenesis of MS by targeting IL-21R.

We also recommend Trading Suppliers and Manufacturers of (21R)-3β,12β,16β-Trihydroxy-21-methyl-30-nor-A'-neogammaceran-22-one (cas 11049-57-3). Pls Click Website Link as below: cas 11049-57-3 suppliers

Prev:Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant
Next:Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis)